First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate
| dc.contributor.affiliation | Universidad del Desarrollo | |
| dc.contributor.affiliation | Universidad de Talca | |
| dc.contributor.affiliation | Universidad de Las Americas - Chile | |
| dc.contributor.author | Vial, Pablo A. | |
| dc.contributor.author | Gonzalez, Claudia | |
| dc.contributor.author | Apablaza, Mauricio | |
| dc.contributor.author | Vial, Cecilia | |
| dc.contributor.author | Lavin, M.Estela | |
| dc.contributor.author | Araos, Rafael | |
| dc.contributor.author | Rubilar, Paola | |
| dc.contributor.author | Icaza, Gloria | |
| dc.contributor.author | Florea, Andrei | |
| dc.contributor.author | Perez, Claudia | |
| dc.contributor.author | Concha, Paula | |
| dc.contributor.author | Bastias, Diego | |
| dc.contributor.author | Errazuriz, Maria Paz | |
| dc.contributor.author | Perez, Ruth | |
| dc.contributor.author | Guzman, Francisco | |
| dc.contributor.author | Olea, Andrea | |
| dc.contributor.author | Guzman, Eugenio | |
| dc.contributor.author | Correa, Juan | |
| dc.contributor.author | Munita, Jose Manuel | |
| dc.contributor.author | Aguilera, Ximena | |
| dc.date.accessioned | 2022-08-11T22:53:36Z | |
| dc.date.available | 2022-08-11T22:53:36Z | |
| dc.date.issued | 2022-09 | |
| dc.description.abstract | Background: The first wave of SARS-CoV-2 infection in Chile occurred during the cold season reaching a peak by the end of June 2020, with 80 % of the cases concentrated in its capital, Santiago. The main objective of this study was to estimate the attack rate during this first wave of SARS-CoV-2 in a large, densely populated city with more than seven million inhabitants. Since the number of confirmed cases provides biased information due to individuals' potential self-selection, mostly related to asymptomatic patients and testing access, we measured antibodies against SARS-CoV-2 to assess infection prevalence during the first wave in the city, as well as estimate asymptomatic cases, and infection fatality ratio. To our knowledge this is one of the few population-based crosssectional serosurvey during the first wave in a highly affected emerging country. The challenges of pandemic response in urban settings in a capital city like Santiago, with heterogeneous subpopulations and high mobility through public transportation, highlight the necessity of more accurate information regarding the first waves of new emerging diseases.Methods: From April 24 to June 21, 2020, 1326 individuals were sampled from a long-standing panel of household representatives of Santiago. Immunochromatographic assays were used to detect IgM and IgG antibody isotypes.Results: Seroprevalence reached 6.79 % (95 %CI 5.58 %-8.26 %) in the first 107 days of the pandemic, without significant differences among sex and age groups; this figure indicates an attack rate 2.8 times higher than the one calculated with registered cases. It also changes the fatality rate estimates, from a 2.33 % case fatality rate reported by MOH to an estimated crude 1.00 % (CI95 % 0.97-1.03) infection fatality rate (adjusted for test performance 1.66 % [CI95 % 1.61-1.71]). Most seropositive were symptomatic (81,1 %).Conclusions: Despite the high number of cases registered, mortality rates, and the stress produced over the health system, the vast majority of the people remained susceptible to potential new epidemic waves. We contribute to the understanding of the initial spread of emerging epidemic threats. Consequently, our results provide better information to design early strategies that counterattack new health challenges in urban contexts. | |
| dc.description.sponsorship | Universidad del Desarrollo Santiago, Chile [202001]; To the panel participants and their families. This work was supported by a COVID-19 Emergency Funding Effort #202001 by Universidad del Desarrollo Santiago, Chile. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Epidemics, 40, 100606. https://doi.org/10.1016/j.epidem.2022.100606 | |
| dc.identifier.doi | https://doi.org/10.1016/j.epidem.2022.100606 | |
| dc.identifier.issn | 1755-4365 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-4135-0416 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-3192-3428 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-8153-6733 | |
| dc.identifier.orcid | https://orcid.org/0000-0001-8075-0626 | |
| dc.identifier.orcid | https://orcid.org/0000-0003-1306-3791 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-0612-8780 | |
| dc.identifier.orcid | https://orcid.org/0000-0003-2385-3455 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-7870-1056 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-0399-6144 | |
| dc.identifier.orcid | https://orcid.org/0000-0003-3578-459X | |
| dc.identifier.pmid | 35872438 | |
| dc.identifier.researcherid | JOJ-6799-2023 | |
| dc.identifier.researcherid | D-9861-2014 | |
| dc.identifier.researcherid | HZJ-5414-2023 | |
| dc.identifier.researcherid | G-7589-2016 | |
| dc.identifier.researcherid | ISA-7550-2023 | |
| dc.identifier.researcherid | KJL-9752-2024 | |
| dc.identifier.researcherid | GVS-4266-2022 | |
| dc.identifier.ror | https://ror.org/05y33vv83 | |
| dc.identifier.ror | https://ror.org/028ynny55 | |
| dc.identifier.ror | https://ror.org/01s4gpq44 | |
| dc.identifier.ror | https://ror.org/0166e9x11 | |
| dc.identifier.scopusauthorid | 17339613100 | |
| dc.identifier.scopusauthorid | 16241501200 | |
| dc.identifier.scopusauthorid | 56845856600 | |
| dc.identifier.scopusauthorid | 55553152400 | |
| dc.identifier.scopusauthorid | 57435798400 | |
| dc.identifier.scopusauthorid | 34976138500 | |
| dc.identifier.scopusauthorid | 57031794200 | |
| dc.identifier.scopusauthorid | 6603110170 | |
| dc.identifier.scopusauthorid | 57435864000 | |
| dc.identifier.scopusauthorid | 56779441600 | |
| dc.identifier.scopusauthorid | 57435749700 | |
| dc.identifier.scopusauthorid | 57898476900 | |
| dc.identifier.scopusauthorid | 57814383300 | |
| dc.identifier.scopusauthorid | 56992094400 | |
| dc.identifier.scopusauthorid | 57814383400 | |
| dc.identifier.scopusauthorid | 36838940600 | |
| dc.identifier.scopusauthorid | 59361840900 | |
| dc.identifier.scopusauthorid | 58817630500 | |
| dc.identifier.scopusauthorid | 24825037700 | |
| dc.identifier.scopusauthorid | 6603011009 | |
| dc.identifier.uri | https://repositorio.udla.cl/handle/udla/1125 | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier BV | |
| dc.relation.funding | Universidad del Desarrollo Santiago | |
| dc.relation.funding | Universidad del Desarrollo Santiago, Chile [202001] | |
| dc.relation.isindexedby | Web of Science | |
| dc.relation.issn | 1755-4365 | |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | https://www.elsevier.com/tdm/userlicense/1.0/ | |
| dc.source | EPIDEMICS | |
| dc.source.uri | https://doi.org/10.1016/j.epidem.2022.100606 | |
| dc.subject | Chile | |
| dc.subject | Seroprevalence | |
| dc.subject | COVID-19 | |
| dc.subject | Pandemic | |
| dc.subject | SARS-COV-2 | |
| dc.subject | Infection fatality rate | |
| dc.subject | IgG | |
| dc.subject | IgM | |
| dc.subject | First wave | |
| dc.subject.lcsh | COVID-19 (Disease) | |
| dc.subject.lcsh | Pandemics | |
| dc.subject.oecd1 | 3 Ciencias Médicas y de la Salud | |
| dc.subject.oecd2 | 3.3 Ciencias de la Salud | |
| dc.subject.oecd3 | 3.3.8 Enfermedades Infecciosas | |
| dc.title | First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate | |
| dc.title.alternative | First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate. | |
| dc.type | journal article | |
| dc.type.coar | http://purl.org/coar/resource_type/c_6501 | |
| dc.type.driver | info:eu-repo/semantics/article | |
| dc.udla.catalogador | CBM | |
| oaire.citation.title | EPIDEMICS | |
| oaire.citation.volume | 40 | |
| udla.curacion.control | jmvg | |
| udla.ods | ODS 3: Salud y bienestar | |
| udla.oecd.area | 3 Ciencias Médicas y de la Salud | |
| udla.oecd.discipline | 3.3.8 Enfermedades Infecciosas | |
| udla.oecd.subarea | 3.3 Ciencias de la Salud |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Vial.2022.First wave of SARS-CoV-2 in Santiago Chile Seroprevalence, asymptomatic infection and infection fatality rate.pdf
- Size:
- 2.12 MB
- Format:
- Adobe Portable Document Format
- Description:
- Vial.2022.First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: